When was Bliss Bio founded?

Bliss Bio was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is Bliss Bio located?

Bliss Bio is headquartered in United States.

Is Bliss Bio a funded company?

Bliss Bio is a funded company, having raised a total of $61.3M across 2 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Apr 19, 2021.

When was the latest funding round of Bliss Bio?

Bliss Bio's latest funding was a $***** Series B round on Jun 07, 2023, with participation from 1 investor. Its primary sector is Diversified Pharmaceuticals. In United States, the Diversified Pharmaceuticals sector has seen $585M in funding in 2026 to date.

Bliss Bio - 2026 Company Profile & Funding

Most viewed in 2019

Bliss Bio is a series B company based in United States, founded in 2017. It operates as a R&D company focused on manufacturing anti tumor drugs for multiple therapeutic areas. Bliss Bio has raised $61.3M in funding from Eisai and GL Ventures.

Key Metrics

Founded Year

2017

Location

United States

Stage

Series B

Total Funding

$61.3M in 2 rounds

Latest Funding Round

Series B, Jun 07, 2023, $*****

Investors

Eisai & 7 more

View Bliss Bio's full profile

Bliss Bio has raised a total funding of $61.3M over 2 rounds. Its first funding round was on Apr 19, 2021. Its latest funding round was a Series B round on Jun 07, 2023 for $*****. 1 investor participated in its latest round. Bliss Bio has 8 institutional investors.